| 121 |
Non-neoplastic variants of the sternum:SPECT/ CT findings |
2015 |
| 122 |
Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. |
2015 |
| 123 |
Pre-treatment Serum Osteoprotegerin, and P53 Protein Levels and Urine Telomerase as prognostic factors affecting survival in Egyptian Bladder Cancer Patients. |
2015 |
| 124 |
Role of 18F-FDG PET/CT in the Detection of Ovarian Cancer Recurrence in the Setting of Elevated Tumor Markers. |
2015 |
| 125 |
Role of 18F-FDG PET/CT in the Detection of Ovarian Cancer Recurrence in the Setting of Elevated Tumor Markers. |
2015 |
| 126 |
The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma |
2015 |
| 127 |
The Value of Postoperative Baseline Serum Thyroglobulin in Prediction of the Outcome of Radioactive Iodine-131 Thyroid Ablation in differentiated thyroid carcinoma |
2015 |
| 128 |
Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. |
2015 |
| 129 |
Thyroid Remnant Ablation of Differentiated Thyroid Carcinoma: a comparison of Ablation success with High and Low Doses of Radioiodine. |
2015 |
| 130 |
Vergleich der Biologisch Effektiven Dosen bei der Brustbestrahlung mittels Simultan Integriertem und Sequentiellem Boost |
2015 |
